Battelle breakthrough could help autistic children receive treatment sooner

Battelle scientists have identified a low-cost urine test that potentially predicts the presence of autism spectrum disorder (ASD) at an early age.

ASD, which is defined by behavioral characteristics, has been difficult for physicians to diagnose at an early age before these behaviors become more apparent (usually about two years of age or older). Recent research indicates that ASD affects 1 in 88 children in the U.S.

The Battelle team of Drs. Nicholas Heyer and Diana Echeverria joined with Professor James Woods at the University of Washington’s School of Public Health to evaluate the levels of porphyrins in the urine of children with ASD to determine if certain levels of specific porphyrins could predict ASD.

Identifying this link may have important clinical implications for diagnosis and treatment. The ability to detect porphyrins, a group of naturally occurring organic compounds, in a simple urine test allows for a rapid, low-cost and widely used screening test for identifying young children at a high risk for ASD.

“This is significant because it means children may be diagnosed with ASD at an earlier age and can thus receive treatment sooner. Early treatment can lead to a better quality of life for children with ASD,” Heyer said.

The findings were published in this month’s edition of Autism Research, and coincide with Autism Awareness Month.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

University of Toledo Medical Center’s new $36M simulator makes training nearly real | Toledo Blade, April 23, 2014

Aerpio Therapeutics closes $22M financing led by OrbiMed (pdf) | Aerpio Therapeutics, April 23, 2014

CTI Clinical Trial & Consulting Services continues to grow with promotions and new hires | Cincinnati.com, April 22, 2014

Austen BioInnovation Institute in Akron presenting two FDA events in one day, April 29 | Austen BioInnovation Institute in Akron, April 22, 2014

OSU collaboration with California’s Oakbio awarded $500k from Canada’s CCEMC to develop biofuels | PR Newswire, April 22, 2014

OSU students’ non-polluting KAir battery wins $100K from US DOE | Columbus Business First, April 22, 2014

The Medical Imaging Technology Partnering Forum part of Cleveland’s medical imaging strength | Cleveland.com, April 22, 2014

Akebia Therapeutics stock rose 55% last week, from below $17 to above $26 | Cincinnati Business Courier, April 21, 2014

The Austen BioInnovation Institute in Akron working with Nottingham Spirk, a Cleveland-based design firm | Akron Beacon Journal, April 21, 2014

CincyTech discusses recent funding for Assurex Health & Sirrus (Bioformix) | Cincinnati Business Courier, April 21, 2014

Akron Children’s joins with Cincinnati Children’s to offer access to new cancer treatments | Akron Beacon Journal, April 20, 2014

OSU Biomedical Engineering students and OncoFilter partners Kinshuk Mitra and Brett Geiger featured on 10TV Columbus | WBNS 10TV Columbus, April 19, 2014

Case Western Reserve University event emphasizes a constellation of research (slideshow) | Cleveland.com, April 19, 2014

Airway Therapeutics granted orphan designation for its product to prevent BPD by European regulatory authority | Cincinnati.com, April 19, 2014

Assurex Health and Sirrus (Bioformix) lead 2014 Q1 funding rounds | Cincinnati.com, April 18, 2014

PhRMA Annual Meeting keynote speakers available on YouTube | PhRMA, April 18, 2014

Alkermes CEO Richard Pops speaks with Xconomy about building the business | Xconomy.com, April 18, 2014

Case Western Reserve University scientists discuss a portable malaria detector (video) | Inside Science TV, April 18, 2014

Ashland University Schar Nursing College starts Doctor of Nursing Program | WMFD Mansfield, April 18, 2014

Kent State Researchers discover new liquid crystal structure | Kent State University, April 17, 2014